ArticleFrontiers in surgery2022

Polo-like kinase (PLK) 5, a new member of the PLK family, serves as a biomarker to indicate anabatic tumor burden and poor prognosis for resectable non-small cell lung cancer.

Kaichao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.